Baijin Life Science(01466.HK): Profit Warning, Expected Annual Loss Widens to No More Than HK$43 Million
NewTimeSpace News: On June 29, 2026, Baijin Life Science(01466.HK) released a profit warning. Based on an initial assessment of the Group’s unaudited consolidated management accounts, the Company anticipates incurring a loss of no more than HK$43 million for the year ended March 31, 2026, as compared with a loss of around HK$100,000 registered in the preceding financial year.
The Board attributes the significant rise in loss mainly to decreased revenue and gross profit from the jewellery business segment, coupled with higher selling expenses incurred by the skincare business segment.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.